TREATMENT OF PSORIASIS.
CORIODERMINA
Coriodermina is a placental factor that inhibits the development of psoriatic crisis regulating the speed of the epidermis cells’ reproduction or queratinocites, through the neutralization of the stimulating effect of various quimical mediators of the inflammatory process, such as neurepeptides and cytokines. It is presented in form of a hydro soluble jelly which acts in the dermis layer by transcutaneous adsorption from the site of application.
Disclaimer: The content provided in Medical Tourism Magazine (MedicalTourism.com) is for informational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. We do not endorse or recommend any specific healthcare providers, facilities, treatments, or procedures mentioned in our articles. The views and opinions expressed by authors, contributors, or advertisers within the magazine are their own and do not necessarily reflect the views of our company. While we strive to provide accurate and up-to-date information, We make no representations or warranties of any kind, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained in Medical Tourism Magazine (MedicalTourism.com) or the linked websites. Any reliance you place on such information is strictly at your own risk. We strongly advise readers to conduct their own research and consult with healthcare professionals before making any decisions related to medical tourism, healthcare providers, or medical procedures.
